Page last updated: 2024-09-02

ramosetron and Female Genital Diseases

ramosetron has been researched along with Female Genital Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Do, SH; Hwang, JW; Jee, BC; Kim, K; Kim, YB; Lee, B; Lee, JR; No, JH; Shin, HJ; Suh, DH	1

Trials

1 trial(s) available for ramosetron and Female Genital Diseases

Article	Year
Efficacy of Single-dose and 2-dose Intravenous Administration of Ramosetron in Preventing Postoperative Nausea and Vomiting After Laparoscopic Gynecologic Operation: A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial. Surgical laparoscopy, endoscopy & percutaneous techniques, 2017, Volume: 27, Issue:3 Topics: Administration, Intravenous; Adult; Antiemetics; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Genital Diseases, Female; Humans; Laparoscopy; Pain, Postoperative; Postoperative Care; Postoperative Nausea and Vomiting; Treatment Outcome	2017

Article

Year

Efficacy of Single-dose and 2-dose Intravenous Administration of Ramosetron in Preventing Postoperative Nausea and Vomiting After Laparoscopic Gynecologic Operation: A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial.

Surgical laparoscopy, endoscopy & percutaneous techniques, 2017, Volume: 27, Issue:3

Topics: Administration, Intravenous; Adult; Antiemetics; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Genital Diseases, Female; Humans; Laparoscopy; Pain, Postoperative; Postoperative Care; Postoperative Nausea and Vomiting; Treatment Outcome

2017